Healthcare provider profile · identity verified

Brian Lee Schulman, MD

Internal Medicine · LOUISVILLE, KY · NPI 1497721120

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	778	249
Amlodipine Besylate	Amlodipine Besylate	390	134
Lisinopril	Lisinopril	351	112
Metoprolol Succinate	Metoprolol Succinate	325	103
Omeprazole	Omeprazole	321	108
Levothyroxine Sodium	Levothyroxine Sodium	317	109
Metformin Hcl Er	Metformin Hcl	304	99
Losartan Potassium	Losartan Potassium	244	82
Simvastatin	Simvastatin	240	70
Meloxicam	Meloxicam	215	74
Pantoprazole Sodium	Pantoprazole Sodium	188	58
Rosuvastatin Calcium	Rosuvastatin Calcium	187	70
Hydrochlorothiazide	Hydrochlorothiazide	185	57
Montelukast Sodium	Montelukast Sodium	162	62
Gabapentin	Gabapentin	158	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	158	28
Tamsulosin Hcl	Tamsulosin Hcl	153	49
Allopurinol	Allopurinol	140	47
Eliquis	Apixaban	140	32
Tramadol Hcl	Tramadol Hcl	139	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	134	43
Metformin Hcl	Metformin Hcl	133	46
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	130	42
Zolpidem Tartrate	Zolpidem Tartrate	117	28
Jardiance	Empagliflozin	103	28
Alprazolam	Alprazolam	100	26
Pravastatin Sodium	Pravastatin Sodium	98	31
Furosemide	Furosemide	97	36
Trazodone Hcl	Trazodone Hcl	96	33
Ezetimibe	Ezetimibe	93	34
Ozempic	Semaglutide	93	17
Carvedilol	Carvedilol	88	32
Escitalopram Oxalate	Escitalopram Oxalate	88	27
Glimepiride	Glimepiride	84	33
Albuterol Sulfate Hfa	Albuterol Sulfate	81	41
Fluticasone Propionate	Fluticasone Propionate	76	33
Januvia	Sitagliptin Phosphate	67	18
Sertraline Hcl	Sertraline Hcl	63	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	61	18
Citalopram Hbr	Citalopram Hydrobromide	58	21
Clonazepam	Clonazepam	56	20
Atenolol	Atenolol	55	17
Metoprolol Tartrate	Metoprolol Tartrate	50	18
Benazepril Hcl	Benazepril Hcl	48	19
Famotidine	Famotidine	48	18
Synthroid	Levothyroxine Sodium	48	17
Clopidogrel	Clopidogrel Bisulfate	47	16
Lorazepam	Lorazepam	47	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	suppressed
Methylprednisolone	Methylprednisolone	45	44
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	44	13
Fluoxetine Hcl	Fluoxetine Hcl	43	14
Tizanidine Hcl	Tizanidine Hcl	42	26
Duloxetine Hcl	Duloxetine Hcl	40	17
Potassium Chloride	Potassium Chloride	38	17
Paxlovid	Nirmatrelvir/Ritonavir	36	36
Pioglitazone Hcl	Pioglitazone Hcl	35	suppressed
Diazepam	Diazepam	33	11
Verapamil Er	Verapamil Hcl	33	suppressed
Spironolactone	Spironolactone	30	13
Hydralazine Hcl	Hydralazine Hcl	29	16
Pregabalin	Pregabalin	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	25
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Repatha Sureclick	Evolocumab	25	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Finasteride	Finasteride	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Naproxen	Naproxen	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	14
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	11
Irbesartan	Irbesartan	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Valsartan	Valsartan	19	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	suppressed
Baclofen	Baclofen	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Ramipril	Ramipril	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Ondansetron Odt	Ondansetron	14	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Colchicine	Colchicine	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Etodolac	Etodolac	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Glipizide	Glipizide	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Naratriptan Hcl	Naratriptan Hcl	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error